{{Rsnum
|rsid=1167849
|Gene=IL20RA
|Chromosome=6
|position=137027888
|Orientation=plus
|GMAF=0.3618
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IL20RA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 44.6 | 49.2
| HCB | 4.4 | 13.3 | 82.2
| JPT | 0.0 | 27.3 | 72.7
| YRI | 90.3 | 9.7 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 13.3 | 82.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}haplotype CCG ([[rs1184860]], [[rs1167846]], [[rs1167849]]) is significantly associated with [[psoriasis]] (OR 3.14, 95% CI 1.61-6.14), whereas the TTG haplotype had a protective effect (OR 0.20, 95% CI 0.07-0.55).

{{PMID Auto
|PMID=18480827
|Title=Association analysis of IL20RA and IL20RB genes in psoriasis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}